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Abstract
Background: The protozoan parasite Trichomonas vaginalis is the most common non-viral, sexually transmitted
pathogen. Although T. vaginalis is highly prevalent among women in Kenya, there is lack of data regarding
genetic diversity of isolates currently in circulation in Kenya.
Methods: Typing was performed on 22 clinical isolates of T. vaginalis collected from women attending the antenatal
care clinic at Kilifi County Hospital, Kenya, in 2015. Genotyping followed a previously proposed restriction fragment
length polymorphism (RFLP) scheme, which involved in silico cleavage of the amplified actin gene by HindII, MseI and
RsaI restriction enzymes. Phylogenetic analysis of all the sequences was performed to confirm the results obtained by
RFLP-analysis and to assess the diversity within the RFLP genotypes. Additionally, we determined carriage of the four
different types of Trichomonas vaginalis viruses (TVVs) by polymerase chain reaction.
Results: In silico RFLP-analysis revealed five actin genotypes; 50.0% of the isolates were of actin genotype E, 27.3%
of actin genotype N, 13.6% of actin genotype G and 4.5% of actin genotypes I and P. Phylogenetic analysis was in
agreement with the RFLP-analysis, with the different actin genotypes clustering together. Prevalence of TVVs was
43.5% (95% confidence interval, CI: 23.2–65.5). TVV1 was the most prevalent, present in 39.1% of the strains and
90% of the T. vaginalis isolates which harbored TVVs had more than one type of TVV. None of the isolates of actin
genotype E harbored any TVV.
Conclusion: The presence of five actin genotypes in our study suggests notable diversity among T. vaginalis
isolates occurring among pregnant women in Kilifi, Kenya. Isolates of the most prevalent actin genotype E
lacked TVVs. We found no association between T. vaginalis genotype, carriage of TVVs and symptoms. Further
studies with higher number of strains should be conducted in order to corroborate these results.
Keywords: Trichomonas vaginalis, Trichomonas vaginalis viruses, actin gene, Typing, Kilifi, Kenya
Background
Trichomonas vaginalis is a flagellated protozoan parasite
that infects the human urogenital tract, causing the most
common non-viral, sexually transmitted infectious
disease worldwide [1]. The prevalence of T. vaginalis
among women in sub-Saharan Africa is 11.5% [1]. In
about half of the infected women, T. vaginalis causes a
malodorous vaginal discharge, vulval irritation and
inflammation, and a ‘strawberry cervix’ characterized by
punctate hemorrhagic lesions [2]. Men typically remain
asymptomatic, but can suffer from urethral discharge,
dysuria, urethritis, epididymitis and prostatitis [2, 3].
Trichomonas vaginalis has been associated with adverse
pregnancy outcomes, such as preterm birth and prema-
ture rupture of membranes [4–6], increased shedding
and acquisition of the human immunodeficiency virus
(HIV) [7, 8], hence contributing to the HIV pandemic.
The global prevalence of T. vaginalis and the health
sequelae associated with it have necessitated the need to
understand its genetic make-up. Trichomonas vaginalis is a
complex pathogen, with a genome size of ~160 megabases,
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two-thirds of which is composed of repeats and transpos-
able elements [9]. Some strains of T. vaginalis can harbor
up to four types of Trichomonas vaginalis viruses (TVVs)
[10]. TVVs are members of the family Totiviridae under
the distinct genus Trichomonasvirus [11]. Carriage of TVVs
has been suggested to upregulate pro-inflammatory host
responses [12] and T. vaginalis immunogenic protein P270
[13] and is also associated with differential qualitative and
quantitative expression of cysteine proteinases [14]. Thus,
since TVVs induce various phenotypic changes that may
impact T. vaginalis virulence [14], determining carriage of
TVVs seems to be essential in the characterization of T.
vaginalis infection. However, no method has been adapted
as a standard clinical diagnostic test for TVVs [15].
Better understanding the diversity of T. vaginalis and
geographical distribution of various genotypes may
improve our knowledge regarding the epidemiology of this
infectious agent and contribute to vaccine development
efforts. At present, none of the described techniques have
been recognized as the “gold standard” for genotyping of
T. vaginalis isolates [16–23].
In this study, we opted to sequence the T. vaginalis
actin gene to better understand the genetic diversity of
T. vaginalis. Actin is a ubiquitous well conserved struc-
tural protein in all eukaryotic cells [24] and has been
used to clarify the molecular phylogeny of protists,
plants, animals and fungi [25].
The data produced by sequencing are unambiguous,
reproducible and portable, thus offering the advantage that
public databases can be constructed. In Kenya, screening
for T. vaginalis is not routinely done. However, recent stud-
ies have indicated that there is high prevalence of T.
vaginalis among different groups in Kenya [26–29]. Despite
this, no typing has been carried out. In this study, we
genotyped T. vaginalis isolated from pregnant women
attending ANC in Kilifi, Kenya.
Methods
Study design, population and specimens processing
From July through to September 2015, we conducted a
cross-sectional study at the antenatal care clinic of Kilifi
County Hospital, Kenya. The main aim of that study was
to describe the prevalence and predictors of curable sexu-
ally transmitted infections (STIs) among pregnant women
attending to the antenatal care clinic [29]. Women were
eligible if they met the following criteria: age 18–45 years,
gestation ≥ 14 weeks, resident of the Kilifi Health and
Demographic Surveillance area, willingness to undergo
free STI and bacterial vaginosis screening procedures, and
able and willing to give written informed consent [29].
The current study presents a secondary objective of the
above-mentioned study, namely to perform typing of T.
vaginalis clinical isolates from this study population.
A total of 349 pregnant women were included in the
study. A nurse collected vaginal secretions from the
vaginal introitus using a sterile cotton swab. The vaginal
swab was inoculated at the clinic in the upper-chamber
of an InPouch system (BioMed Diagnostics, White City,
Oregon, USA). The inoculated InPouch was transferred
to the laboratory within 15 min for direct microscopy of
the upper chamber, after which it was merged with the
lower chamber and incubated at 37 ± 1 °C under aerobic
conditions. Daily microscopic observation of the
InPouch system was performed and media with motile
trichomonads within 5 days of culture were considered
positive for T. vaginalis. Two ml of the contents of each
InPouch system positive for T. vaginalis were transferred
into a 2.0 ml Eppendorf tube and stored at -80 °C until
shipment to the Laboratory of Bacteriology Research
(Ghent University, Belgium) using shipping boxes filled
with dry ice (-78.5 °C). The samples were stored at -80 °C
until molecular analysis was performed.
Women found to be positive for T. vaginalis using
direct microscopy, i.e. microscopy of the upper chamber,
were treated on the same day, while women who were
negative for T. vaginalis using direct microscopy but
positive on culture were contacted to return to the clinic
for treatment immediately after the culture turned positive.
Partners of women treated for T. vaginalis infection re-
ceived presumptive treatment.
Nucleic acid extraction
Frozen cultures were first thawed at room temperature
for 30 min, after which the tubes were vortexed for 30 s
to ensure that a homogeneous mix was achieved before
starting the nucleic acid extraction. Total nucleic acid ex-
traction was performed using the NucliSENS® easyMAG®
(bioMérieux, Marcy l’Etoile, France) according to the
manufacturer’s instructions (generic protocol 2.0.1).
Actin gene PCR
The actin gene was amplified using the outer primers
previously used in a nested polymerase chain reaction
(PCR), i.e. primers Tv8S (5′-TCT GGA ATG GCT
GAA GAA GAC G-3′) and Tv9R (5′-CAG GGT
ACA TCG TAT TGG TC-3′) [20], with the following
thermocycling conditions: 5 min at 95 °C, 40 cycles
of 30 s at 95 °C, 30 s at 55 °C and 3 min at 72 °C,
followed by 7 min at 72 °C. This was performed on
the ABI Veriti thermocycler platform (ThermoFisher
Scientific, Waltham, Massachusetts, USA).
Gel electrophoresis
PCR amplification products were visualized under UV light
after electrophoresis on 1% agarose gels in Tris-acetate-
EDTA buffer pH 8.5 (30 min at 10 V/cm) and staining with
ethidium bromide (0.5 mg⁄ l; Sigma, Bornem, Belgium). The
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size of the amplified products was assessed by compari-
son with a commercial weight marker, Smart Ladder
(Eurogentec, Liege, Belgium).
Sequencing
Amplicons (20 μl) were sent for sequencing to GATC
Biotech (Constance, Germany), using the Sanger sequen-
cing technique. Sequencing was performed bi-directionally
using the same primers used in PCR amplification of the
actin gene.
Genotyping of T. vaginalis
Trichomonas vaginalis actin sequences were edited using
Chromas Lite 2.01 (http://technelysium.com.au/wp/). Fur-
thermore, we identified the T. vaginalis actin genotypes
amongst our isolates by means of in silico RFLP-analysis
Webcutter version 2.0; http://rna.lundberg.gu.se/cutter2/
with the three restriction enzymes (HindII, MseI and RsaI)
used by Crucitti et al. [20]. The in silico analysis was done
on our clinical isolates and on retrieved sequences repre-
senting the genotypes that have been proposed. To identify
if there were additional T. vaginalis actin genotypes not
captured by the previous proposed scheme, in silico
RFLP was performed on actin sequences retrieved
from the GenBank whose actin genotype is yet to be
documented. The sequences were of at least 1100 bp
in length (Additional file 1: Table S1).
To compare results obtained in the RFLP analysis, and
to determine the genetic variation among the identified
genotypes, we performed phylogenetic analysis of the se-
quences. Sequences obtained in our study were aligned
using MEGA software and compared with analogous se-
quences representative of known T. vaginalis actin ge-
notypes identified in from our isolates.
Evolutionary distances were calculated by Kimura’s
two-parameter model (Kimura, 1980) and a phylogenetic
tree was generated using the Maximum Likelihood
method using the MEGA software (version 7.0) [30]. Fi-
nally, confidence levels were estimated using bootstrap
resampling on 1000 randomly selected pseudoreplicates.
Detection of Trichomonas vaginalis viruses
Synthesis of cDNA was performed on the nucleic acid
extract using the RevertAid First Strand cDNA Synthesis
Kit (ThermoFisher Scientific, Gent, Belgium). The cDNA
was used to amplify the four known TVVs by means of
previously described type specific primers: TVV1F2875 (5′-
ATT AGC GGT GTT TGT GAT GCA-3′) and
TVV1R3443 (5′-CTA TCT TGC CAT CCT GAC TC-3′),
TVV2F1401 (5′-ATT AGC GGT GTT TGT GAT GCA-
3′) and TVV2R1953b (5′-GGT TCG TGG AAG CGG
TTG ATG A-3′), TVV3F1474 (5′-CTA CCA AGA AGG
AGG CTT GA-3′) and TVV3R2025b (5′-GGT TCG TGG
AAG CGG TTG ATG A-3′), and TVV4F1338 (5′-ATG
CCA GTT GCT TTC CG-3′) and TVV4R1834 (5′-TTC
CCC AATAGT TAT CAG-3′) [10]. The amplification con-
ditions were: 5 min at 95 °C, 40 cycles of 30 s at 95 °C, 30 s
at 50 °C and 45 s at 72 °C, followed by 7 min at 72 °C. The
PCR products were visualized by electrophoresis as de-
scribed above.
Statistical analysis
The socio-demographic and clinical data of the partici-
pants were entered in the REDCapTM electronic data
capture tool, version 6.5.0 (Vanderbilt University, Nashville,
Tennessee). Prevalence of T. vaginalis was expressed as a
percentage with exact 95% binomial confidence intervals
(CIs). Univariable logistic regression was used to de-
termine associations of T. vaginalis presence with
socio-demographic data, hygienic data, sexual behav-
ior, and vaginal signs & symptoms. Variables signifi-
cant at P ≤ 0.1 in bivariable analysis were entered
into a multivariable model to identify independent as-
sociations. Crude odds ratios (COR) and adjusted
odds ratios (AOR) were calculated. These statistical
analyses were done using STATA, version 13.1
(Stata-Corp, College Station, Texas).
Results
Characteristics of the study population
The median age and gestation age including the inter-
quartile range (IQR) for the participants was 27 (22–31)
years and 25 (20–30) weeks, respectively. The majority
of the participants were married (93.6%) and Christian
(72.3%). Approximately a quarter of the participants had
received secondary school education and above. The
median age and IQR of sexual debut was 18.6 (16–20)
years, although 17.4% of the participants were not sure
or did not respond to this question. Seventy-three
percent of the participants had given birth before and
the number of children ranged between 1 and 10. Sixty-
five percent of the participants had previously experi-
enced signs/symptoms associated with reproductive tract
infection and about one third had ever received syndromic
treatment for genital signs or symptoms of infection. The
socio-demographic characteristics of the participants are
summarized in Table 1.
Prevalence, clinical signs and symptoms
A total of 23/349 (6.6%, 95% CI: 4.2–9.7) women
were culture-positive for T. vaginalis, and 34.8% of
these cases were positive by direct microscopy prior
to further incubation. Based on symptoms routinely
used in syndromic management of STIs (i.e. genital
ulcer, lower abdominal pain or abnormal vaginal discharge),
43.5% of the 23 women with T. vaginalis infection were
asymptomatic. The most commonly self-reported symp-
toms amongst all participants included vaginal discharge
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Table 1 Univariable and multivariable analysis of characteristics
of pregnant women with T. vaginalis attending antenatal care
clinic at Kilifi County Hospital, Kenya
Variable N = 349 Percentage with
T. vaginalis
Crude OR
(95% CI)
P-value
Demographic characteristics
Age group (years)
18–24 132 6.8 1.1 (0.4–2.5) 0.894
≥ 25 217 6.5
Religion
Christian 248 5.7
Muslim 54 5.7 1.0 (0.3–3.5) 0.979
Other/None 47 12.8 2.4 (0.9–6.7) 0.083a
Education
None 63 7.9
Primary 200 7.0 0.9 (0.3–2.5) 0.802
Secondary/Tertiary 86 4.7 0.6 (0.1–2.1) 0.411
Marital status
Single 25 4.0
Married 224 6.8 1.7 (0.2–13.5) 0.593
Residency
Living with partner 255 5.5
Not living with a
partner
94 9.6 1.8 (0.8–4.4) 0.178
Employment status
Employed/self-
employed
199 5.0
Unemployed 150 8.7 1.8 (0.8–4.2) 0.180
Parity
0 94 6.4 1.1 (0.3–3.5) 0.843
1–2 133 7.5 1.3 (0.5–3.6) 0.570
3+ 122 5.7
Gestational age (weeks)c
14–25 183 5.5
≥ 26 165 7.9 1.5 (0.6–3.4) 0.382
Hygiene characteristics
Toilet type
Flushing toilet 117 7.7
Pit latrine 197 5.1 0.6 (0.3–1.6) 0.350
Bush/Other 35 11.4 1.5 (0.4–5.4) 0.491
Mode of cleaning after visiting the toilet
Tissue paper/Other
solid materials
106 2.8
Water 243 8.2 3.1 (0.9–10.5) 0.074a
Behavioral characteristics
Sexual debut age (years)
≤ 17 106 8.5 1.8 (0.7–4.7) 0.231
≥ 18 183 4.9
Do not know/No
response
60 6.7 1.5 (0.4–5.0) 0.523
Table 1 Univariable and multivariable analysis of characteristics
of pregnant women with T. vaginalis attending antenatal care
clinic at Kilifi County Hospital, Kenya (Continued)
Variable N = 349 Percentage with
T. vaginalis
Crude OR
(95% CI)
P-value
Number of lifetime sex partnersc
1 158 3.8
2+ 189 9.0 2.5 (1.0–6.5) 0.060a
Polygamous partner
No 303 6.9 1.6 (0.4–7.2) 0.515
Yes 46 4.4
Alcohol consumption ever
No 262 6.5 0.9 (0.4–2.5) 0.894
Yes 87 6.9
Tobacco use
No 332 6.6 1.1 (0.1–8.9) 0.904
Yes 17 5.9
Other drugs/substance use ever
No 332 6.6 1.1 (0.1–8.9) 0.904
Yes 17 5.9
Sexually transmitted infections/reproductive tract infections
HIV
Negative 324 6.2
Positive 25 12.0 2.1 (0.6–7.5) 0.268
Bacterial vaginosisd
Negative 293 6.5
Positive 53 7.6 1.1 (0.4–3.6) 0.775
Clinical signs and symptoms of STI
Previous history of vaginal discharge
No 122 5.6
Yes 227 7.1 1.2 (0.5–3.1) 0.638
Previous syndromic treatment of genital infection
No 229 6.6
Yes 120 6.7 1.0 (0.4–2.5) 0.967
Current vaginal discharge (self-reported)c
No 96 3.1
Yes 252 7.9 2.7 (0.8–9.2) 0.119
Abnormal vaginal discharge foul smell/color (observed)c
No 271 5.9
Yes 77 9.1 1.6 (0.6–4.0) 0.324
Dysuriac
No 263 6.1
Yes 85 8.2 1.4 (0.5–3.5) 0.489
Dyspareuniac
No 245 4.9
Yes 103 10.7 2.3 (1.0–5.4) 0.053
Vaginal itchingc
No 231 6.5
Yes 117 6.8 1.1 (0.4–2.6) 0.903
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(72.4%). However, during collection of specimens by the
study nurse, only 22.1% of the participants had an abnormal
discharge (defined as excess discharge/foul smelling dis-
charge/colored discharge) upon examination. A total of
51.4% of the women reported having lower abdominal pain,
genital ulcers were observed in 2.9% of the women. Dyspar-
eunia, genital warts and genital ulcers were the only clinical
signs or symptoms significantly associated with T. vaginalis
infection (Chi-square test: χ2 = 3.93, df = 1, P < 0.048;
χ2 = 5.58, df = 1, P < 0.018; and χ2 = 18.60, df = 1, P < 0.05,
respectively).
Predictors of T. vaginalis infection
Univariable analysis indicated that T. vaginalis infection
was more common among participants who were
traditionalist or reported having no religion compared to
participants who were Christians or Muslims, used water
to clean themselves after visiting the toilet compared to
those who used tissue paper or other solid materials, re-
ported having ≥ 2 lifetime sexual partners, reported
dyspareunia, had genital warts, and/or had a genital
ulcer (Table 1). In multivariable analysis, the only inde-
pendent predictor associated with T. vaginalis was hav-
ing a genital ulcer (AOR = 7.6, 95% CI: 1.4–42.3).
Genotyping analysis
The actin gene target could be amplified from 21 of the
23 T. vaginalis isolates. All 21 amplicons had the ex-
pected length of approximately 1100 bp. The two
remaining isolates could only be amplified by a higher
primer concentration of 0.5 μM, instead of 0.3 μM.
However, one of these clinical isolates did not yield an
interpretable sequence and thus only sequences from 22
clinical isolates were utilized in the typing. Five different
actin types (E, G, I, N and P) were identified according
to the position and the number of cleavage sites, follow-
ing the scheme proposed by Crucitti et al. [20] (Table 2).
The most prevalent actin genotype was E, representing
50.0% of the isolates. The other genotypes were, in order
of descending frequency, N (27.3%), G (13.6%) and I and
P (each 4.5%).
Multiple sequence analysis to compare polymorphic sites
found on our actin sequences, and those retrieved from the
GenBank, revealed a total of 33 single nucleotide differ-
ences in the open reading frame of the actin gene. Three of
these single nucleotide polymorphisms were exclusively
found in actin sequences from our study (Additional file 2).
The nucleotide sequences obtained of the actin gene for all
the 22 isolates were submitted in GenBank under accession
numbers: (MF350322–MF350343). The phylogenetic ana-
lysis (Fig. 1) showed that actin genotype E clustered with a
bootstrap value of 99. Lower bootstrap values were ob-
served for actin genotypes N, G, I and P.
Prevalence of T. vaginalis viruses
TVVs were present in 43.5% (95% CI: 23.2–65.5) (10/23)
of T. vaginalis isolates. Trichomonas vaginalis virus type
1 (TVV1) was the most prevalent (39.1%), followed by
Table 1 Univariable and multivariable analysis of characteristics
of pregnant women with T. vaginalis attending antenatal care
clinic at Kilifi County Hospital, Kenya (Continued)
Variable N = 349 Percentage with
T. vaginalis
Crude OR
(95% CI)
P-value
Lower abdominal painc
No 169 8.3
Yes 179 5.0 0.6 (0.2–1.4) 0.226
Genital wartsc
No 341 6.2
Yes 7 28.6 6.1 (1.1–33.3) 0.037a
Genital ulcer (observed)c
No 338 5.6
Yes 10 40.0 11.2 (2.9–43.1) < 0.001b
Vaginitisc
No 334 6.6
Yes 14 7.1 1.1 (0.1–8.7) 0.935
Symptomaticc
No 145 6.9
Yes 203 6.4 0.9 (0.4–2.2) 0.855
aSignificant in univariable analysis
bSignificant on multivariable association; symptomatic (any or a
combination of the three symptoms, i.e. genital ulcer, lower abdominal
pain or abnormal vaginal discharge)
cMissing data/some participants did not respond to this question(s)
dBacterial vaginosis results for three participants were not available due to
poor slides
Table 2 Number and position of restriction sites using HindII, MseI and RsaI restriction enzymes
Genotype No. of
isolates
HindII MseI RsaI
213 273 699 185 314 518 103 190 426 878 994
E 11 × × × × × × × ×
G 3 × × × × × × ×
I 1 × × × × × × × ×
N 6 × × × × × × × × ×
P 1 × × × × × × × × ×
× indicates the presence of a restriction cut site
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TVV2 (26.1%), TVV3 (17.4%) and TVV4 (13.0%). Nine
out of 10 T. vaginalis isolates with TVVs harbored more
than one type of TVV (Table 3). TVV1 was present in
all virus-positive T. vaginalis isolates but one (TV207).
All 11 genotype E isolates were virus-negative.
Finally, the distribution of symptomatic and asymptom-
atic cases was not linked to any particular T. vaginalis actin
genotype. Similarly, presence or absence of TVVs did not
appear to have an influence as to whether a patient was
symptomatic or asymptomatic.
Discussion
To our knowledge, this is the first study determining T.
vaginalis genotypes and co-occurrence of T. vaginalis vi-
ruses in Kenya. We sequenced the actin gene for 22 isolates
and identified five types of T. vaginalis by in silico RFLP-
analysis of the amplified actin gene. We found notable gen-
etic diversity by full actin gene sequence analysis among T.
vaginalis isolates in Kilifi, as well as those retrieved from
GenBank. Prevalence of T. vaginalis in this study (6.6% in
349 pregnant women) was high but, however, fell short of
the prevalence of T. vaginalis among women aged 15–
49 years in the World Health Organization Africa region in
2012, which was estimated to be 11.5% (95% CI: 9.0–14.6)
[1]. This is suggestive of lower rates of T. vaginalis among
the general population of women in Kilifi, Kenya compared
to other African countries [31].
Although T. vaginalis does not traditionally present with
genital ulcers [32], multivariable analysis showed that
genital ulcers were the only predictor of an infection with
T. vaginalis in our study. Ulcers could not be due to
syphilis, which was not diagnosed in any of the women
with T. vaginalis, but we did not test for the Herpes
simplex virus, which is also associated with genital ulcers.
The association of genital ulcer with T. vaginalis is not
unique to our study as it has been reported amongst female
sex workers in China [33].
Nucleotide sequence analysis of actin sequences showed
33 polymorphic sites, three of which caused amino acid
substitution. Two of these amino acid substitutions have
been previously reported to occur in genotypes G, N, I and
P, in which nucleotide 371 substituted alanine for valine,
and nucleotide 904 substituted lysine for glutamine [20,
34]. A unique polymorphism leading to an amino acid
Fig. 1 Phylogenetic tree for actin gene nuclotide sequences of T. vaginalis. The tree was generated using Maximum Likelihood method.
Bootstrap test for 1000 replicates. Sequences from Kilifi isolates (n = 22) have accession numbers with the prefix “MF”, all other sequences were
retreived from GenBank and are representative of the five actin genotypes. Scale-bar: 0.001 (1 substitution per 1000 nucleotides)
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substitution, in which nucleotide 892 substituted
threonine for serine, was observed to be exclusively
present on a GenBank sequence (accession number
XM_001301892). As such, in silico genotyping of
isolates provides an opportunity to distinguish closely
related isolates based on these polymorphic sites and
to further identify such polymorphic sites.
Our phylogenetic analysis confirms RFLP as a good
typing method, as the results from this method were in
agreement with phylogenetic analysis. Phylogenetic ana-
lysis and detection of carriage of TVVs, revealed that
none of the isolates of the most prevalent actin genotype
E harbored a TVV. Furthermore, phylogenetic analysis
indicated that genotype E formed a distinct phylogenetic
lineage, suggesting clonal stability of this genotype [35].
The high prevalence (43.5%) of TVVs found in this
study is comparable to a prevalence of 55% (95% CI:
38.4–70.7) among Cuban isolates [36]. Two recent
studies have reported lower carriage of TVV, 18.7% (95%
CI: 11.5–28.0) in the Philippines [37] and 17.3% (95%
CI: 7.8–31.4) among Iranian isolates [38], although the
latter study only determined the presence of TVV1.
However, higher prevalence rates of TVV have been re-
ported as well, 81.9% (95% CI: 71.1–90.0) in South
Africa [39], and 75.0% (95% CI: 55.1–89.3) in Baltimore
City, Maryland [40]. The presence of TVV, in addition
to metronidazole susceptibility, has been found to differ
significantly between T. vaginalis isolates genotyped by a
panel of 21 microsatellites and six single-copy genes of
T. vaginalis, which classifies T. vaginalis into two types:
type 1 and type 2 [23]. Type 2 is characteristically free of
TVV and resistant to metronidazole [23]. Metronidazole
susceptibility in relation to actin genotypes is yet to be
determined.
Fifty-seven percent of isolates in our study did not
harbor TVV, suggesting that they might be of type 2.
Our study might have been biased towards type 2;
63.6% were recovered from patients who were diag-
nosed by culture, after direct microscopy had been
determined to be negative, suggesting that the para-
site load in the patient was low. Conrad et al. [23]
observed that type 1 parasites are often diagnosed by
direct microscopy and suggested that this may be in-
dicative of higher parasite load in type 1 which har-
bor TVVs. Additional studies, sampling a more
diverse population and other regions in Kenya, are
needed to confirm the population type and distribu-
tion of T. vaginalis in the country.
A total of 22 TVVs were identified in 10 T. vaginalis
cultures, with multiple TVVs detected in nine cultures
(Table 2). The higher prevalence of T. vaginalis cultures
with either TVV1 or TVV2 than with TVV3 or TVV4 is
consistent with previous reports [10, 37]. In these publi-
cations, concurrent TVV infection, with at least two or
3 TVVs, was recorded in six and three T. vaginalis sam-
ple cultures, respectively. Although we identified single
actin genotypes in all T. vaginalis cultures, which is indi-
cative for the presence of only 1 T. vaginalis strain per
culture, we cannot rule out that the presence of the mul-
tiple TVVs may be the result of a mixture of T. vaginalis
strains, each infected with a different TVV. Therefore,
our data does not necessarily indicate concurrent infec-
tion of TVVs in a single TV strain. The lytic cycle of
TVVs is yet to be described, and attempts to infect
uninfected isolates have been unsuccessful [41]. There-
fore, it is plausible that the virus may solely be acquired
through vertical transmission, making its presence an
important genetic marker [42].
Fifty-six percent of women with T. vaginalis infection in
our study were symptomatic and the symptoms occurred
independently of the presence of TVV in the protozoon.
In vitro studies have shown that TVVs are sensed by the
Table 3 Genotypes of Trichomonas vaginalis and carriage of T.
vaginalis viruses, in relation to symptoms among 23 T. vaginalis
isolates in Kilifi, Kenya
Sample ID TVV1 TVV2 TVV3 TVV4 Genotype Symptomatica
TV279 + – + – * +
TV022 – – – – E +
TV042 – – – – E +
TV050 – – – – E –
TV066 – – – – E +
TV075 – – – – E +
TV176 – – – – E –
TV188 – – – – E –
TV203 – – – – E +
TV224 – – – – E –
TV299 – – – – E +
TV323 – – – – E –
TV185 + – + + G –
TV207 – + – – G +
TV238 + + + – G +
TV307 + + – – I –
TV116 + + – – N –
TV131 + + – – N +
TV156 + – – + N –
TV190 + + + – N +
TV210 – – – – N +
TV234 + – – + N –
TV140 – – – – P +
Abbreviations: TVV1 Trichomonas vaginalis virus type 1, TVV2 T. vaginalis virus
type 2, TVV3 T. vaginalis virus type 3, TVV4 T. vaginalis virus type 4
Code: *Not typed; + present; − absent
aSymptomatic: any or a combination of the three symptoms, i.e. genital ulcer,
lower abdominal pain and/or abnormal vaginal discharge
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human epithelial cells via Toll-like receptor 3, triggering
Interferon Regulating Factor − 3, interferon type I and
pro-inflammatory cascades previously implicated in
preterm birth and HIV-1 susceptibility [12]. While
treatment with metronidazole generally eliminates T.
vaginalis, this may aggravate T. vaginalis-associated
inflammation caused by the release of TVV by stressed
or dying parasites [12]. Additionally, TVVs upregulate
levels of phenotypically variable immunogen mRNA
P270 of T. vaginalis [13], while also playing a role in
T. vaginalis protein composition and its growth
kinetics [14].
Conclusion
Our study was limited by the small number of isolates,
which rendered it difficult to investigate the implication
of TVV carriage on clinical signs and symptoms. Despite
the low number of T. vaginalis isolates, the presence of
all four types of TVVs in our isolates, in addition to the
five actin genotypes, demonstrates there is notable
genetic diversity of T. vaginalis isolated from pregnant
women in Kilifi, Kenya. Isolates of the most prevalent
actin genotype E lacked TVVs; further studies with
higher number of strains should be conducted in order
to corroborate these results. The actin gene should be
considered as a potential genetic marker for molecular
epidemiology and genotypic traits of T. vaginalis.
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